According to our data shown in Table 1, SCARB1 is one of the top predicted targets for fenofibrate interaction, and investigation in the curated database revealed its relationship to NAFLD. The gene discussed is SCARB1; the disease is metabolic dysfunction-associated steatotic liver disease.